Marc Filaire

Marc Filaire

Auto-generated profile, based on publicly available information

Marc Filaire

Université Clermont Auvergne, INRAE, UNH, F-63000, Clermont-Ferrand, France.

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2017 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
RBRea Bingula
Rea Bingula
MFMarc Filaire
Marc Filaire
NRNina Radosevic-Robin
Nina Radosevic-Robin
MBMathieu Bey
Mathieu Bey
JBJean-Yves Berthon
Jean-Yves Berthon
EFEdith Filaire
Edith Filaire
The microbiota includes different microorganisms consisting of bacteria, fungi, viruses, and protozoa distributed over many human body surfaces including the skin, vagina, gut, and airways, with the highest density found in the intestine. The gut microbiota strongly influences our metabolic, endocrine, and immune systems, as well as both the peripheral and central nervous systems. Recently, a dialogue between the gut and lung microbiota has been discovered, suggesting that changes in one compartment could impact the other compartment, whether in relation to microbial composition or function. Further, this bidirectional axis is evidenced in an, either beneficial or malignant, altered immune response in one compartment following changes in the other compartment. Stimulation of the immune system arises from the microbial cells themselves, but also from their metabolites. It can be either direct or mediated by stimulated immune cells in one site impacting the other site. Additionally, this interaction may lead to immunological boost, assisting the innate immune system in its antitumour response. Thus, this review offers an insight into the composition of these sites, the gut and the lung, their role in shaping the immune system, and, finally, their role in the response to lung cancer.

1 January 2016 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
RBRea Bingula
Rea Bingula
CDCarmen Dupuis
Carmen Dupuis
CPChantal Pichon
Chantal Pichon
JBJean-Yves Berthon
Jean-Yves Berthon
MFMarc Filaire
Marc Filaire
EFEdith Filaire
Edith Filaire
We investigated the effects of betaine, C-phycocyanin (C-PC), and their combined use on the growth of A549 lung cancer bothin vitroandin vivo.When cells were coincubated with betaine and C-PC, an up to 60% decrease in viability was observed which is significant compared to betaine (50%) or C-PC treatment alone (no decrease). Combined treatment reduced the stimulation of NF-κB expression by TNF-αand increased the amount of the proapoptotic p38 MAPK. Interestingly, combined treatment induced a cell cycle arrest in G2/M phase for ~60% of cells.In vivostudies were performed in pathogen-free male nude rats injected with A549 cells in their right flank. Their daily food was supplemented with either betaine, C-PC, both, or neither. Compared to the control group, tumour weights and volumes were significantly reduced in either betaine- or C-PC-treated groups and no additional decrease was obtained with the combined treatment. This data indicates that C-PC and betaine alone may efficiently inhibit tumour growth in rats. The synergistic activity of betaine and C-PC on A549 cells growth observedin vitroremains to be further confirmedin vivo.The reason behind the nature of their interaction is yet to be sought.

1 February 2008 in Journal des Maladies Vasculaires
Verified
Journal Article
Closed access
NBN. Bourry
N. Bourry
PCP. Chabrot
P. Chabrot
GJG. Jeannin
G. Jeannin
MFM. Filaire
M. Filaire
CCC. Charpy
C. Charpy
LBL. Boyer
L. Boyer